Algert Global LLC Collegium Pharmaceutical, Inc Transaction History

Algert Global LLC

  • $2.55 Billion
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 12, 2020
SELL
$15.49 - $23.51 $812,311 - $1.23 Million
-52,441 Closed
0 $0
Q1 2020

May 13, 2020
BUY
$13.89 - $25.45 $728,405 - $1.33 Million
52,441 New
52,441 $856,000
Q2 2019

Aug 14, 2019
SELL
$10.62 - $16.59 $149,051 - $232,840
-14,035 Closed
0 $0
Q1 2019

May 01, 2019
BUY
$13.58 - $18.72 $190,595 - $262,735
14,035 New
14,035 $212,000

Others Institutions Holding COLL

# of Institutions
231
Shares Held
39.5M
Call Options Held
104K
Put Options Held
15.4K
View Full List

About COLLEGIUM PHARMACEUTICAL, INC

COLL Quotes by TradingView
  • Ticker COLL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 34,126,200
  • Market Cap $1.1B
  • Description
  • Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...
More about COLL
Track This Portfolio

Track Algert Global LLC Portfolio

Follow Algert Global LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

News

Stay updated on Algert Global LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email